GB1473318A - Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof - Google Patents
Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereofInfo
- Publication number
- GB1473318A GB1473318A GB2523773A GB2523773A GB1473318A GB 1473318 A GB1473318 A GB 1473318A GB 2523773 A GB2523773 A GB 2523773A GB 2523773 A GB2523773 A GB 2523773A GB 1473318 A GB1473318 A GB 1473318A
- Authority
- GB
- United Kingdom
- Prior art keywords
- concentration
- therapeutically useful
- ethyl cellulose
- cellulose
- carboxychromon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1473318 Pharmaceutical compositions FISONS Ltd 15 May 1974 [25 May 1973 (2) 12 July 1973] 25237/73 25238/73 and 33325/73 Addition to 1399834 Heading A5B Pharmaceutical compositions comprise a substantially clear sterile aqueous solution containing, as active ingredient, a therapeutically useful proportion of 1, 3-bis (2-carboxychromon-5-yloxy)-propan-2-ol, or a pharmaceutically acceptable salt thereof, and comprising an additional compound which is therapeutically useful in the eye, or an additive to increase the viscosity or to prolong the action of the active ingredient, or wherein the concentration of "metal ions" is less than 20 ppm, or wherein the concentration of Mg<++> is less than 0.2 ppm, or comprising dextrose or mannitol, or comprising sodium citrate/citric acid, or boric acid/sodium borate, or containing a concentration of chelating or sequestering agent in the range of from 0.005 to 0.1 % w/v. The additional therapeutically useful compounds include anti-histamines e.g. antazoline or diphenhydramine hydrochloride; anti-inflammatory agents e.g. prednisolone; antibacterials e.g. sulphacetamide and propamidine isethionate; antibiotics e.g. tetracycline, chloramphenicol, neomycin and fromycetin; antimycotics e.g. nystatin and amphotericin B; decongestants e.g. phenylephrine; anti-viral agents e.g. idoxuridine and vasoconstrictors e.g. oxymetazoline. The viscosity increasing additive may be methyl cellulose, hydroxypropylmethyl cellulose hydroxy propyl ethyl cellulose, hydroxy ethyl cellulose, ethyl hydroxy ethyl cellulose, a polyvinyl alcohol, gelatin, polyvinyl pyrrolidone, a polyethylene glycol, a propylene glycol and/or glycerin. The compositions may be used in the treatment of allergic conditions of the eyes and nose. Reference has been directed by the comptroller to Specification 1144905.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2523773A GB1473318A (en) | 1973-05-25 | 1973-05-25 | Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof |
US05/471,141 US3975536A (en) | 1971-05-12 | 1974-05-17 | Composition |
FR7417407A FR2230358A2 (en) | 1973-05-25 | 1974-05-20 | Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine |
DE19742425281 DE2425281A1 (en) | 1973-05-25 | 1974-05-24 | PHARMACEUTICAL COMPOSITION |
JP49058021A JPS5756448B2 (en) | 1973-05-25 | 1974-05-24 | |
US05/677,274 US4053628A (en) | 1971-05-12 | 1976-04-15 | Composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2523773A GB1473318A (en) | 1973-05-25 | 1973-05-25 | Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1473318A true GB1473318A (en) | 1977-05-11 |
Family
ID=10224431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2523773A Expired GB1473318A (en) | 1971-05-12 | 1973-05-25 | Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1473318A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2464716A1 (en) * | 1979-09-07 | 1981-03-20 | Upjohn Co | COMPOSITION CONTAINING A DISODIUM CHROMOGLYCATE BIOLOGIST FOR THE PREVENTION OR TREATMENT OF MINERAL PATHOLOGICAL RESORPTION CONDITIONS IN LIVING PLANTS |
GB2167300A (en) * | 1984-11-23 | 1986-05-29 | Fisons Plc | Nasal/opthalmic sodium cromoglycate preparation |
BE1005196A0 (en) * | 1992-07-07 | 1993-05-18 | Fisons Plc | AQUEOUS PHARMACEUTICAL COMPOSITIONS OF SODIUM CROMOGLYCATE. |
GB2262448A (en) * | 1992-07-07 | 1993-06-23 | Fisons Plc | Aqueous formulations of sodium cromoglycate |
-
1973
- 1973-05-25 GB GB2523773A patent/GB1473318A/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2464716A1 (en) * | 1979-09-07 | 1981-03-20 | Upjohn Co | COMPOSITION CONTAINING A DISODIUM CHROMOGLYCATE BIOLOGIST FOR THE PREVENTION OR TREATMENT OF MINERAL PATHOLOGICAL RESORPTION CONDITIONS IN LIVING PLANTS |
GB2167300A (en) * | 1984-11-23 | 1986-05-29 | Fisons Plc | Nasal/opthalmic sodium cromoglycate preparation |
BE1005196A0 (en) * | 1992-07-07 | 1993-05-18 | Fisons Plc | AQUEOUS PHARMACEUTICAL COMPOSITIONS OF SODIUM CROMOGLYCATE. |
GB2262448A (en) * | 1992-07-07 | 1993-06-23 | Fisons Plc | Aqueous formulations of sodium cromoglycate |
FR2686513A1 (en) * | 1992-07-07 | 1993-07-30 | Fisons Plc | Aqueous pharmaceutical compositions of sodium cromoglycate |
EP0587264A1 (en) * | 1992-07-07 | 1994-03-16 | FISONS plc | Aqueous pharmaceutical formulations of sodium cromoglycate |
GB2262448B (en) * | 1992-07-07 | 1994-03-30 | Fisons Plc | Aqueous pharmaceutical formulations of sodium cromoglycate |
US5475023A (en) * | 1992-07-07 | 1995-12-12 | Fisons Plc | Aqueous pharmaceutical formulations of sodium cromoglycate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6776982B2 (en) | Autoclavable pharmaceutical compositions containing a chelating agent | |
US6576649B1 (en) | Method for treating pharmaceutical compositions | |
ES2542728T3 (en) | Pharmaceutical compositions that have desirable bioavailability | |
US4607038A (en) | Ophthalmic pranoprofen compositions | |
US4201706A (en) | Treatment of corneal edema | |
US4053628A (en) | Composition | |
US20140088107A1 (en) | Ophthalmic preparation comprising a pgf2alpha analogue | |
US6291519B1 (en) | Method of preventing damage to eye tissue | |
US3975536A (en) | Composition | |
US20120190653A1 (en) | Therapeutic eye drop comprising doxycycline and a stabilizer | |
GB1473318A (en) | Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof | |
IE36337L (en) | Pharmaceutical compositions | |
DE2425281A1 (en) | PHARMACEUTICAL COMPOSITION | |
US10610509B2 (en) | Combinations of prostaglandins and nitric oxide donors | |
ES2358558T3 (en) | THIOPHENE DERIVATIVES AS MEDICINES FOR THE TREATMENT OF EYE HYPERTENSION. | |
JP2001131055A (en) | Liquid agent, removal of white cloudiness of liquid agent and acceleration of trans-mucous membrane absorption of liquid agent | |
NO179472B (en) | Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes | |
CA2529860A1 (en) | Ophthalmic composition | |
KR100392481B1 (en) | Dexamethasone gel | |
HUT63060A (en) | Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists | |
EP0212927B1 (en) | Pharmaceutical composition comprising sodium cromoglycate and a mucolytic agent | |
US5733938A (en) | Combination of levobunolol and dipivefrin for topical ophthalmic use | |
TWI712429B (en) | Water-based pharmaceutical composition | |
TR201603837A1 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed |